Company intelligence / Profile preview

Innovative BioCeramix

Ownership: Private
Employees: ~3
Development stage: Commercial

Overview

Innovative BioCeramix has developed and commercialized several advanced biomaterial-based dental products, including injectable root canal sealers and repair materials. These products have received regulatory approvals from the US FDA, CE Mark in Europe, Health Canada, and China SFDA. The company continues to develop next-generation dental and orthopedic devices based on proprietary bioceramic technologies

Therapeutic areas: OtherInfectious Diseases
Modalities: DeviceBiomaterial-based therapy (hydraulic bioceramic paste, calcium silicate composition)
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Innovative BioCeramix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innovative BioCeramix.

Explore the full profile